Kisspeptin

Sexual Health · Hormonal Axis Subcutaneous Injectable

Kisspeptin is a master regulator of the reproductive hormone axis. It signals upstream at the hypothalamus, stimulating your body's own production of testosterone, estrogen, and other sex hormones — making it particularly useful for natural support of low T, fertility optimization, and hormonal-axis recalibration.

Best for: Natural support of low T, fertility optimization, hormonal axis rebooting.

Lab-guided protocolsPersonalized dosingProvider-led oversightIn-clinic & telehealth Lab-guided protocolsPersonalized dosingProvider-led oversightIn-clinic & telehealth

The questions, answered.

  • Stimulates natural sex-hormone production via hypothalamic signaling.
  • Supports fertility in both men and women.
  • Improves libido and arousal through hormone-axis restoration.
  • Useful for post-TRT recovery or natural T support.
  • Preserves the body's own hormone-regulation systems.
  • Promising for hypothalamic amenorrhea and related fertility issues.
  • KISS1R activation on GnRH neurons in the hypothalamus.
  • Pulsatile GnRH release — restores the natural rhythm.
  • LH and FSH stimulation downstream from pituitary.
  • Preserves the HPG axis rather than overriding it.
  • Weeks 1–2: Lab markers begin to shift; subtle libido or energy changes.
  • Weeks 4–6: Hormone panels often show meaningful restoration of natural production.
  • Weeks 8–12: Axis recalibration consolidates; many clients move to maintenance or cycling.
  • Mild injection-site reaction.
  • Transient libido or mood shifts as hormones recalibrate.
  • Headache — uncommon and short-lived.
  • Cycle changes in women early in protocol — typically a positive sign.
  • Pair with comprehensive labs — track LH, FSH, total/free T, estrogen.
  • Stay consistent with timing — pulsatile dosing matters.
  • Discuss with your provider if used post-TRT or alongside fertility planning.
  • Lifestyle still counts: sleep, training, and nutrition amplify the response.
  • Pregnancy outside of provider supervision.
  • Hormone-sensitive cancers without oncology oversight.
  • Active pituitary disease — discuss with endocrinology.
  • Known peptide hypersensitivity.
Important Note The FDA's position on peptides continues to evolve. Availability of specific compounds may change, and not all peptides discussed are currently offered at every visit. Book a consultation with our provider team to discuss your goals, current options, and what's appropriate for you.

Layered with intention.

— Begin

Precision protocols.
Designed around you.

Every TAI peptide protocol is lab-guided and provider-led. Start with biomarkers, design around your goals, refine at intervals. Available in-clinic and via telehealth.

Book Consult Membership pricing